Updated Jul 16, 2026
Kim Hanjoon Alex has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $4K.
Hanjoon Alex Kim is the Chief Financial Officer of Standard BioTools Inc., a company focused on developing technologies for biomedical research. He has been involved in various SEC filings related to the company's financial activities.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-22 | LAB | STANDARD BIOTOOLS INC. | F — Tax withholding / forfeiture | 18.9K | $1.00 | $19K |
| 2026-04-09 | LAB | STANDARD BIOTOOLS INC. | F — Tax withholding / forfeiture | 21.3K | $0.91 | $19K |
| 2026-04-09 | LAB | STANDARD BIOTOOLS INC. | M — Option exercise | 70.2K | $0.00 | |
| 2026-04-09 | LAB | STANDARD BIOTOOLS INC. | A — Grant or award | 323.2K | $0.00 | |
| 2026-02-24 | LAB | STANDARD BIOTOOLS INC. | F — Tax withholding / forfeiture | 12.7K | $1.15 | $15K |
| 2025-11-24 | LAB | STANDARD BIOTOOLS INC. | F — Tax withholding / forfeiture | 12.7K | $1.28 | $16K |
| 2025-08-20 | LAB | STANDARD BIOTOOLS INC. | F — Tax withholding / forfeiture | 12.7K | $1.27 | $16K |
| 2025-08-01 | LAB | STANDARD BIOTOOLS INC. | A — Grant or award | 1.50M | $0.00 | |
| 2025-05-28 | LAB | STANDARD BIOTOOLS INC. | F — Tax withholding / forfeiture | 2.6K | $1.09 | $3K |
| 2025-05-23 | LAB | STANDARD BIOTOOLS INC. | S — Open-market sale | 1.4K | $0.94 | $1K |
| 2025-05-22 | LAB | STANDARD BIOTOOLS INC. | S — Open-market sale | 1.4K | $1.00 | $1K |
| 2025-05-20 | LAB | STANDARD BIOTOOLS INC. | S — Open-market sale | 1.4K | $1.03 | $1K |
| 2025-05-20 | LAB | STANDARD BIOTOOLS INC. | F — Tax withholding / forfeiture | 6.4K | $1.05 | $7K |
| 2025-04-04 | LAB | STANDARD BIOTOOLS INC. | F — Tax withholding / forfeiture | 21.4K | $1.07 | $23K |
| 2025-04-04 | LAB | STANDARD BIOTOOLS INC. | M — Option exercise | 70.2K | $0.00 |
Hanjoon Alex Kim is the Chief Financial Officer of Standard BioTools Inc., a company focused on developing technologies for biomedical research. He has been involved in various SEC filings related to the company's financial activities.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($4K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Kim Hanjoon Alex profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.